Global University Venturing

TUM’s tech transfer office will begin training 12 impact-focused startups from June 2020 in an accelerator allied to BMW Foundation Herbert Quandt.

Azafaros, a metabolic disorder drug developer leveraging Leiden University and Amsterdam UMC inventions, has secured $28m in series A capital.

The biomedical commercialisation hub will invest $200,000 in four to six startups each year from University of Washington and other local centres of research.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

UPMC will invest some of its recently announced $1bn healthcare commercialisation budget to create a new pharmaceutical development firm.

LaunchLab has entrusted Joshua Romisher with driving its entry into new African markets beyond its existing purview of South Africa.

CU Boulder spinout ALD NanoSolutions has merged with its peer Forge Nano, with new merged company securing $20m from a range of corporates.

Chalmers University of Technology-founded baby ventilation monitor developer Monivent will join the Spotlight Stock Market in an IPO where 60% of shares have advance subscriptions in place.

University of Pennsylvania-linked CNS disorder-focused drug developer Passage Bio has filed to raise up to $125m having raised $226m in funding.

The cancer therapy developer is set to raise between $140m and $160m in its initial public offering, following $226m in funding.

The UBC bioprinting spinout will use part of the funding to progress two of its projects towards commercialisation.